Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brener

Showing results (21-30 of 318) with videos related to

Pageof 32
Sort By:
Journal of Vascular Surgery|December 7, 2002
RegenerationBruce J Brener
JACC. Cardiovascular Interventions|December 21, 2013
Reply: relationship between myocardial reperfusion, infarct size, and mortalitySorin J Brener
Journal of the American College of Cardiology|May 2, 2009
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?Sorin J Brener
JACC. Cardiovascular Interventions|March 24, 2017
More Bad News for Patients With Diabetes and a Thin Silver LiningSorin J Brener
American Journal of Surgery|August 1, 1996
Why am I still doing this?B J Brener
JACC. Cardiovascular Interventions|July 16, 2010
Why we do what we do? Making sense of antithrombotic therapy in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionSorin J Brener
Coronary Artery Disease|April 7, 2016
Biomarker ratios and acute myocardial infarction: when one goes up and the other goes downSorin J Brener
The Journal of Invasive Cardiology|May 29, 2016
Numbers, Numbers, Numbers…So Many Details Hide in Plain Sight! Insights From HEAT-PPCI and HEAT-SEALEDSorin J Brener
Journal of the American College of Cardiology|April 30, 2016
Corin Levels in Patients With Acute MI: Do We Need More Tools for Risk Stratification?Sorin J Brener
JAMA|February 24, 2006
Wish list and REALITY: choice of stents and end points for treatment of de novo coronary artery lesionsSorin J Brener
Pageof 32

Showing results (21-30 of 318) with videos related to

Sort By:
Pageof 32
Journal of Vascular Surgery|December 7, 2002
RegenerationBruce J Brener
JACC. Cardiovascular Interventions|December 21, 2013
Reply: relationship between myocardial reperfusion, infarct size, and mortalitySorin J Brener
Journal of the American College of Cardiology|May 2, 2009
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?Sorin J Brener
JACC. Cardiovascular Interventions|March 24, 2017
More Bad News for Patients With Diabetes and a Thin Silver LiningSorin J Brener
American Journal of Surgery|August 1, 1996
Why am I still doing this?B J Brener
JACC. Cardiovascular Interventions|July 16, 2010
Why we do what we do? Making sense of antithrombotic therapy in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary interventionSorin J Brener
Coronary Artery Disease|April 7, 2016
Biomarker ratios and acute myocardial infarction: when one goes up and the other goes downSorin J Brener
The Journal of Invasive Cardiology|May 29, 2016
Numbers, Numbers, Numbers…So Many Details Hide in Plain Sight! Insights From HEAT-PPCI and HEAT-SEALEDSorin J Brener
Journal of the American College of Cardiology|April 30, 2016
Corin Levels in Patients With Acute MI: Do We Need More Tools for Risk Stratification?Sorin J Brener
JAMA|February 24, 2006
Wish list and REALITY: choice of stents and end points for treatment of de novo coronary artery lesionsSorin J Brener
Pageof 32